Otonomy Files Registration Statement for Proposed Initial Public Offering - KTVN Channel 2 - Reno Tahoe News Weather, Video -

Otonomy Files Registration Statement for Proposed Initial Public Offering

  • Wendy Damonte's Health Watch ReportsMore>>

  • Request Remind Me 2 Kit

    Request a Remind Me 2 Kit

         More >>
  • Health Officials Report Whooping Cough Cases Up in Nevada

    Health Officials Report Whooping Cough Cases Up in Nevada

    Tuesday, July 29 2014 7:01 PM EDT2014-07-29 23:01:35 GMT
    Nevada health officials say the Silver State has seen a rise in pertussis cases over recent years. As of last month, Nevada has had 60 cases of pertussis reported, more than this time last year, hinting towards another year of elevated pertussis cases in the state.More >>
    Nevada health officials say the Silver State has seen a rise in pertussis cases over recent years. As of last month, Nevada has had 60 cases of pertussis reported, more than this time last year, hinting towards another year of elevated pertussis cases in the state.More >>
  • Generation of Tanners See Spike in Deadly Melanoma

    Generation of Tanners See Spike in Deadly Melanoma

    Tuesday, July 29 2014 2:55 PM EDT2014-07-29 18:55:14 GMT
    The acting U.S. surgeon general is asking Americans to give up their love of sunbathing and indoor tanning beds, citing an alarming 200% jump in the number of deadly melanoma cases diagnosed since 1973.More >>
    The acting U.S. surgeon general is asking Americans to give up their love of sunbathing and indoor tanning beds, citing an alarming 200% jump in the number of deadly melanoma cases diagnosed since 1973.More >>

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Otonomy, Inc.

SAN DIEGO, July 14, 2014 /PRNewswire/ -- Otonomy, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the inner and middle ear, today announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of shares of its common stock. All shares of common stock to be sold in the offering will be offered by Otonomy. The number of shares to be offered and the price range for the proposed offering have not yet been determined.

Otonomy, Inc. Logo

J.P. Morgan Securities LLC and BofA Merrill Lynch are acting as joint book-running managers for the offering, and Piper Jaffray & Co. and Sanford C. Bernstein & Co., LLC are acting as co-managers for the offering.

A registration statement relating to these securities has been filed with the SEC, but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering will be made only by means of a prospectus. When available, copies of the preliminary prospectus may be obtained from J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at (866) 803-9204; or BofA Merrill Lynch, 222 Broadway, New York, NY 10038, Attention: Prospectus Department, or by email at: dg.prospectus_requests@baml.com.

Logo - http://photos.prnewswire.com/prnh/20130806/MM59802LOGO

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and Sarkes Tarzian, Inc. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.